ClinicalTrials.Veeva

Menu
M

Manitoba Clinic | Rheumatology Research Unit

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Upadacitinib
Methotrexate
Adalimumab
ABT-494
Apremilast
Tocilizumab
CP-690,550
MTX
Ocrelizumab
Guselkumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 33 total trials

A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy (KEEPsAKE 1)

The purpose of this study is to compare the safety and efficacy of risankizumab versus placebo in participants with moderately to severely active pso...

Active, not recruiting
Psoriatic Arthritis
Biological: Placebo
Biological: Risankizumab

The purpose of this study was to assess efficacy, including inhibition of radiographic progression, and safety with upadacitinib versus placebo and v...

Active, not recruiting
Rheumatoid Arthritis
Drug: Placebo for Upadacitinib
Drug: Upadacitinib

Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. This study will assess how...

Enrolling
Rheumatoid Arthritis
Drug: Adalimumab
Drug: Upadacitinib

Trial sponsors

AbbVie logo
Amgen logo
Pfizer logo
AbbVie logo
Roche logo
A
CSL Behring logo
Genentech logo
Janssen (J&J Innovative Medicine) logo
MedImmune logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems